Plantable Health Welcomes James (Jim) Wachtel as Chief Growth Officer

Growth Strategist Veteran Joins Plantable To Boost Business Growth

New York, New York–(Newsfile Corp. – June 2, 2022) – Plantable® Health Inc. (NEO: PLBL) (OTCQB: PLBLF) (“Plantable” or the “Company“) today announces it has finalized its senior management team with the hiring of James (Jim) Wachtel as Chief Growth Officer (CGO) effective June 2, 2022. Jim will lead all new business growth, adding to the Company’s aggressive growth strategy, with a primary responsibility of driving Plantable’s institutional partnership growth across self-funded employers, health plans, hospital systems, and other relevant organizations.

Jim joins Plantable with twenty-five years of proven sales leadership and growth strategy experience. Over the last fifteen years, Jim has focused successfully on pioneering new products and services in the health risk management, and employee benefits space helping self-funded employers, brokers, consultants, health plans and payors, manage health risks and reverse chronic disease states, with group sizes from small to tens of thousands of members.

CEO Dr. Nadja Pinnavaia stated: “I am thrilled to welcome Jim to Plantable in this very important role. Plantable brings a proven, turn-key solution that addresses one of the most pressing issues of our time – the reversal of the epidemic of chronic disease by changing dietary behavior. Jim brings a lifetime of experience working across insurers, health plans and self-insured corporates who bear the exploding cost of chronic disease. I couldn’t be more thrilled to have Jim join the senior management team. This final and pivotal appointment now completes our senior hiring needs for the foreseeable future.”

“I am very excited to join Plantable and to share the message around making healthy eating easy,” said Jim Wachtel, Chief Growth Officer. “There have been countless products and strategies over the last 30 years to try and bend the trajectory of metabolic conditions that drive chronic disease, yet the incidence continues to grow. Finally, Plantable is on the scene to make it convenient and easy to eat better and support the reduction of the metabolic drivers of rampant health risks.”

About Plantable® Health Inc.

Plantable is a clinically supported, lifestyle intervention program that combines behavioral psychology, neuroscience, and nutritional science to transform health and wellness. Plantable drives healthy weight loss and an improvement in health, and well-being through effective behavior change. Plantable’s efficacy is predicated upon the scientific foundation of plant-based nutrition, personalized coaching support and lifestyle educational tools to empower people to change their dietary habits. To view the Company’s products and become a customer, please visit plantable.com or click the link here: https://plantable.com

If you are interested in investing in the Company and would like more information, click the link here: http://invest-plantable.com

Become a part of the Plantable investor community on WhatsApp by joining the link here: https://chat.whatsapp.com/CNupoG2sVitJRhzpfGJGHt

On behalf of the Board of Directors,

Dr. Nadja Pinnavaia
Chief Executive Officer

For investor inquiries please contact:

Olenka Slawski
Corporate Communications and Investor Relations
Email: Invest@plantable.com
Phone: 778-200-4926

Cautionary Note Regarding Forward-Looking Information

Certain statements contained in this news release constitute forward-looking statements as defined under applicable securities laws. All statements in this news release, other than statements of historical facts, that address events or developments that management of the Company expect, are forward-looking statements. Specifically, the references in this news release to the benefits the Company expects to gain from appointment of its Chief Growth Officer constitute forward-looking statements. Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond the Company’s control, that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements, see “Notice to Investors – Forward-Looking Information” and “Risk Factors” in the Prospectus. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, save and except as may be required by applicable securities laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/126230